Current use of biologicals in thrombosis and haemostasis.
Ofosu
Frederick A
FA
Barrowcliffe
Trevor W
TW
D000818:Animals; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D003029:Coagulants / Q000009:adverse effects / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006487:Hemostasis / Q000187:drug effects; D020141:Hemostatic Disorders / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy*
D001688:Biological Products; D003029:Coagulants; D005343:Fibrinolytic Agents; D011994:Recombinant Proteins